The genetic ablation of GHSR was found to aggravate the decrease in nigral DA neurons and lower striatal DA levels in PD animal models, which could be reversed by selectively reactivating GHSR in catecholaminergic neurons (Andrews et al., 2009). This evidence concerns the gene GHSR and Parkinson disease.